Buy Macrosyn (Tulathromycin) 100mg/ml Injectable Solution Online: The Definitive Veterinary Guide to Triamilide Subclass Kinetics, Targeted Pulmonary Macrophage Accumulation, and Single-Dose BRD and SRD Metaphylaxis in Cattle and Swine

Controlling bovine respiratory disease (BRD) complex in beef cattle, feedlot calves, and dairy heifers, as well as swine respiratory disease (SRD) in nursery and finishing pigs, is essential for maintaining herd health and operational profitability. Stressors like weaning, transport, co-mingling, and abrupt weather shifts weaken normal mucosal defenses, allowing aggressive bacterial pathogens to colonize the lower respiratory tract.

Left untreated, BRD and SRD cause acute bronchopneumonia, permanent lung tissue consolidation, reduced feed efficiency, and high mortality rates.

In addition to respiratory disease, cattle producers frequently face secondary bacterial infections such as Infectious Bovine Keratoconjunctivitis (IBK / Pinkeye) caused by Moraxella bovis and Interdigital Necrobacillosis (Foot Rot) caused by Fusobacterium necrophorum. Managing these conditions with short-acting antibiotics requires repeated animal handling, increases labor costs, and elevates stress on sick stock.

To deliver extended therapeutic drug levels directly to target lung tissue from a single treatment, veterinary clinicians depend on advanced triamilide macrolides. Macrosyn Injectable Solution (manufactured by Bimeda) is a premier, FDA-approved bioequivalent brand alternative to Draxxin. Powered by Tulathromycin at a concentration of $100\ \text{mg/mL}$, Macrosyn is a subclass of macrolide engineered for rapid absorption, extensive tissue distribution, and prolonged retention in alveolar macrophages, providing multi-day protection against key respiratory and soft-tissue pathogens in cattle and swine.

This comprehensive clinical manual covers triamilide molecular mechanics, pulmonary tissue kinetics, species-specific administration routes, and precise dosing guidelines for Macrosyn.

Triamilide Subclass Pharmacology & Pulmonary Transport Kinetics

Macrosyn delivers a targeted, long-acting antimicrobial mechanism that actively concentrates within pulmonary immune cells:

                  [Macrosyn (Tulathromycin) Injection Administered]
                                         |
               [Rapid Absorption: SQ in Cattle / IM in Swine]
                                         |
             [Active Accumulation in Alveolar Macrophages & Neutrophils]
                                         |
               -------------------------------------------------
              |                                                 |
     [50S RIBOSOMAL BACTERIAL BLOCK]                   [EXTENDED TISSUE HALF-LIFE]
       (Tulathromycin Binding)                       (Maintains Prolonged Lung Levels)
              |                                                 |
              v                                                 v
   [Inhibits Protein Transpeptidation]               [Reaches High Lung-to-Plasma Ratio]
   (Halts Bacterial Translocation)                   (Concentrates Directly at Infection Site)
              |                                                 |
              v                                                 v
   [Rapid Clearance of BRD / SRD Pathogens]          [Provides Up to 14 Days Protection]
              |                                                 |
               =========================> <=====================
                                         |
                                         v
               [Resolution of Pneumonia, Pinkeye, Foot Rot, & SRD]
                                         |
               [Restoration of Normal Growth, Feed Efficiency, & Health]

1. Protein Synthesis Inhibition via Tulathromycin

Tulathromycin ($100\ \text{mg/mL}$) belongs to the triamilide subclass of macrolide antibiotics, distinguished by three amino groups on its chemical structure. It acts by binding reversibly to the 50S subunit of bacterial ribosomes. This blocks transpeptidation and translocation steps required for protein elongation, stopping bacterial replication and allowing host immune defenses to clear the infection.

2. High Lung-to-Plasma Concentration Ratio

Tulathromycin exhibits unique pharmacokinetic properties:

• Rapid Macrophage Uptake: Phagocytic cells (neutrophils and alveolar macrophages) rapidly take up tulathromycin from circulation and transport it directly to inflamed lung tissue.

• Extended Elimination Half-Life: Tulathromycin maintains an exceptionally long elimination half-life in lung tissue (up to 8 days in cattle and 6 days in swine), delivering sustained antimicrobial coverage from a single injection.

Target Pathogen Spectrum

Macrosyn provides broad-spectrum bactericidal and bacteriostatic activity against key production animal pathogens:

• Cattle: Mannheimia haemolytica, Pasteurella multocida, Histophilus somni, Mycoplasma bovis, Moraxella bovis (Pinkeye), and Fusobacterium necrophorum / Porphyromonas levii (Foot Rot).

• Swine: Actinobacillus pleuropneumoniae (APP), Pasteurella multocida, Bordetella bronchiseptica, Haemophilus parasuis (Glasser’s Disease), and Mycoplasma hyopneumoniae.

Core Clinical Indications by Species

Macrosyn 100mg/ml is an essential therapeutic and metaphylactic tool in cattle and swine health programs:

Bovine Indications (Beef Cattle, Non-Lactating Dairy Cattle, & Dairy Calves)

• Treatment & Control of BRD: Indicated for the treatment of BRD and for the control of respiratory disease in cattle at high risk of developing BRD associated with M. haemolytica, P. multocida, H. somni, and M. bovis.

• Treatment of Infectious Bovine Keratoconjunctivitis (Pinkeye): Treats acute pinkeye associated with Moraxella bovis.

• Treatment of Interdigital Necrobacillosis (Foot Rot): Clears acute bovine foot rot associated with F. necrophorum and P. levii.

Swine Indications

• Treatment & Control of SRD: Indicated for the treatment of SRD and for the control of SRD in groups of pigs where SRD has been diagnosed associated with A. pleuropneumoniae, P. multocida, B. bronchiseptica, H. parasuis, and M. hyopneumoniae.

Recommended Administration and Dosing Protocols

To ensure proper absorption and maintain food safety standards, Macrosyn must be administered strictly according to species-approved routes and site volume limits.

Species Dosage and Administration Reference Table

The table below outlines standard clinical dosing parameters for Macrosyn Injectable Solution ($100\ \text{mg/mL}$):

Clinical Safety, Food Safety Compliance, and Storage

• Dairy Cattle Restriction: Do not use in female dairy cattle 20 months of age or older. Use in lactating dairy cattle may cause milk residues.

• Calf Restriction: Do not use in calves to be processed for veal.

• Mandatory Slaughter Withdrawal Periods:

  • Cattle Withdrawal: 18 days slaughter withdrawal following SQ administration.

  • Swine Withdrawal: 5 days slaughter withdrawal following IM administration.

• Site Volume Precautions: Exceeding maximum recommended injection site volumes ($10\ \text{mL}$ in cattle, $2.5\ \text{mL}$ in swine) can cause localized muscle damage or altered depletion kinetics.

• Storage Parameters: Store at controlled room temperature between 20°C and 25°C (68°F to 77°F). Use within 56 days of first puncture.

Frequently Asked Questions (FAQ)

Is Macrosyn bioequivalent to Draxxin?

Yes. Macrosyn contains the active ingredient tulathromycin (100 mg/mL) and is approved by the FDA as an effective bioequivalent alternative to Draxxin®, offering identical clinical performance and dosing for cattle and swine.

How long does a single injection of Macrosyn remain active in lung tissue?

Following a single injection, Macrosyn rapidly concentrates in alveolar macrophages and maintains therapeutic antimicrobial levels in lung tissue for up to 14 days in cattle.

Can Macrosyn be injected intramuscularly (IM) in cattle?

No. In cattle, Macrosyn is approved strictly for Subcutaneous (SQ) injection in the neck. Intramuscular injection in cattle alters tissue depletion kinetics and can cause injection-site lesions.

Where can I buy genuine Macrosyn Injection online?

You can safely purchase authentic, factory-sealed Macrosyn Injectable Solution online through Equines Vet Care. We store and manage all inventory under strict climate-controlled conditions to guarantee absolute product stability and full therapeutic potency.

Secure Premium Sourcing from Equines Vet Care

At Equines Vet Care, we understand that controlling livestock respiratory disease requires absolute product reliability. Every vial of Macrosyn (Tulathromycin) 100mg/ml Injectable Solution is sourced through authorized veterinary distribution networks, stored in our climate-controlled facility, and shipped securely to ensure complete product quality.

Macrosyn Injectable Solution is an antibiotic indicated for the treatment of bovine respiratory disease (BRD), infectious bovine keratoconjunctivitis (pinkeye), and foot rot in beef and non-lactating dairy cattle and for treatment and control of swine respiratory disease (SRD) in swine. Each ml contains 100 mg tulathromycin. The usual recommended dosage of Macrosyn is 1.1 ml per 100 lbs. body weight, given in the neck. Do not administer more than 10 ml SQ per injection site in cattle. One dose provides up to 7-14 days BRD treatment and control. Do not administer more than 5 ml IM per injection site in swine. Not for use in female dairy cattle 20 months of age or older, or in calves to be processed for veal. Tulathromycin.

BRD – Macrosyn Injectable Solution is indicated for the treatment of bovine respiratory disease (BRD) associated with Mannheimia haemolytica, Pasteurella multocida, Histophilus somni, and Mycoplasma bovis; and for the control of respiratory disease in cattle at high risk of developing BRD associated with Mannheimia haemolytica, Pasteurella multocida, Histophilus somni, and Mycoplasma bovis. IBK – Macrosyn Injectable Solution is indicated for the treatment of infectious bovine keratoconjunctivitis (pinkeye) associated with Moraxella bovis.

Foot Rot – Macrosyn Injectable Solution is indicated for the treatment of bovine foot rot (interdigital necrobacillosis) associated with Fusobacterium necrophorum and Porphyromonas levii.

SRD – Macrosyn Injectable Solution is indicated for the treatment of swine respiratory disease (SRD) associated with Actinobacillus pleuropneumoniae, Pasteurella multocida, Bordetella bronchiseptica, Haemophilus parasuis, and Mycoplasma hyopneumoniae; and for the control of SRD associated with Actinobacillus pleuropneumoniae, Pasteurella multocida, and Mycoplasma hyopneumoniae in groups of pigs where SRD has been diagnosed.